PMID: 8969737Dec 1, 1996Paper

Therapy with orally administered methoxsalen and ultraviolet A radiation during childhood increases the risk of basal cell carcinoma. The PUVA Follow-up Study

The Journal of Pediatrics
R S Stern, K T Nichols

Abstract

A child was treated from age 18 months to 8 years with oral methoxsalen and ultraviolet A radiation (PUVA) for refractory psoriasis. Two basal cell cancers developed before age 21 years, suggesting that exposure to PUVA in childhood increases the risk of basal cell cancer.

References


❮ Previous
Next ❯

Citations

Jan 18, 2008·The New England Journal of Medicine·Amy S PallerUNKNOWN Etanercept Pediatric Psoriasis Study Group
Aug 6, 1997·Journal of the National Cancer Institute·M R Gailani, A E Bale
Dec 10, 2015·Biochemistry·Natalia Milosevich, Fraser Hof
May 29, 2007·Journal of the American Academy of Dermatology·Dimitrios Malanos, Robert S Stern
Sep 25, 2001·Journal of the American Academy of Dermatology·M LebwohlP McClelland
Aug 24, 2013·Clinical Medicine Insights. Pediatrics·Irene Lara-CorralesPerla Lansang
Sep 24, 2004·Dermatologic Therapy·Debra Lewkowicz, Alice B Gottlieb
Apr 2, 2005·Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde·J AllaliG Renard
Feb 20, 2018·Dermatopathology·Hannah SongDaniela Kroshinsky
Nov 11, 2009·Journal of the American Academy of Dermatology·Michelle E A de JagerMarieke M B Seyger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Basal Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.